However, these prognostic indices do not capture lymphoma related molecular aberrations causing particularly aggressive high-risk disease, such as cell of origin, activated B-cell type DLBCL, MYC and/or BCL2 and/or BCL6 gene re-arranged or double expressor lymphomas [6]. Here, MYC is linked to lymphoma.